Ranitidine (Zantac) Recall Expanded, Many Questions Remain

Recent Articles

Can men hold off on treating recurring prostate cancer?

Go slower for strength training gains

Does exercising in the evening affect sleep?

Lifestyle counseling may help men eat healthier and reduce their risk for diabetes

A modest level of physical activity may help protect women from health risks

Gum disease may increase the risk for stroke and cognitive decline

How to prep for a successful colonoscopy

How to feed your gut

A fresh approach to cardio exercises

Why you should try ellipticals

/ April 2, 2020 By Joshua Gagne, PharmD, ScD, Contributor Share Share this page to Facebook Share this page to X Share this page via Email Copy this page to clipboard Print This Page Click to Print

Update: On April 1, 2020, the FDA requested manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine drugs (Zantac, others) from the market immediately, due to the presence of a contaminant known as N-Nitrosodimethylamine (NDMA). Although the FDA did not observe unacceptable levels of NDMA in many of the samples they tested, they have determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures. As a result of this recall, ranitidine products will no longer be available for prescription or OTC use in the US.

The FDA is also advising consumers taking OTC ranitidine to stop taking this medication, including any unused ranitidine medication they may still have at home. Other FDA-approved OTC medications are available to treat heartburn. Patients taking prescription ranitidine should speak with their doctor about other treatment options before stopping the medicine.

As anticipated, recall of the popular heartburn medicine ranitidine (Zantac) has expanded. But we still have more questions than answers.

As I mentioned in my original blog post on this topic, the online pharmacy Valisure, which originally alerted the FDA to the issue, found what they called “extremely high levels” of the probable cancer-causing substance N-nitrosodimethylamine (NDMA) in ranitidine products.

The FDA has indicated that its own preliminary testing has detected low levels of NDMA in ranitidine.

Testing methods may have influenced NMDA results

The FDA has clarified that the testing method that found the “extremely high levels” of NDMA applied high heat, at a level much higher than normal body temperature. In other words, the testing did not reflect typical conditions under which the medication would be stored or taken.

The FDA is asking all companies that manufacture ranitidine, as well as other similar medications (both H2 blockers, the class of drugs to which ranitidine belongs, and proton-pump inhibitors, or PPIs, a different class of drugs used for similar conditions), to test their products using lower heat closer to normal body temperature. So far, there is no indication that these other products are affected; the FDA is likely asking for these tests only as a precaution.

As of now, the FDA has allowed ranitidine to remain on the market. Still, some manufacturers have issued voluntary recalls and some pharmacies have pulled it off the shelves.

FDA estimates ranitidine NMDA risk with other medications

The FDA has not yet released the results of its own tests of ranitidine. But they previously estimated the likely impact of NDMA found in another class of medications, called angiotensin receptor blockers, on the risk of cancer. That estimate provides some context for the current circumstances.

Angiotensin receptor blockers, including the drug valsartan (Diovan), are used to treat high blood pressure and other heart conditions. They were recalled beginning last year due to the presence of NDMA and other related impurities. The FDA estimated that, if 8,000 people took the highest dose of valsartan containing NDMA every day for four years, there would be one additional case of cancer over the lifetimes of these 8,000 people.

Currently, we do not know how the amount of NDMA found in ranitidine compares to the amount found in valsartan.

Until we know more, the best course of action if you are taking ranitidine is to talk to your doctor about whether treatment is still needed. For some conditions, the benefits likely outweigh the risks. Although some ranitidine products remain available, consider alternative medications such as cimetidine (Tagamet) or famotidine (Pepcid) if you need long-term treatment.

Follow me on Twitter @JoshuaJGagne

About the Author

Joshua Gagne, PharmD, ScD, Contributor

Joshua J Gagne, PharmD, ScD is an Associate Professor of Medicine at Brigham and Women’s Hospital and Harvard Medical School and an Associate Professor in the Department of Epidemiology at the Harvard T.H. Chan School of … See Full Bio View all posts by Joshua Gagne, PharmD, ScD Share Share this page to Facebook Share this page to X Share this page via Email Copy this page to clipboard Print This Page Click to Print

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Recent Articles

Can men hold off on treating recurring prostate cancer?

Go slower for strength training gains

Does exercising in the evening affect sleep?

Lifestyle counseling may help men eat healthier and reduce their risk for diabetes

A modest level of physical activity may help protect women from health risks

Gum disease may increase the risk for stroke and cognitive decline

How to prep for a successful colonoscopy

How to feed your gut

A fresh approach to cardio exercises

Why you should try ellipticals

/

You might also be interested in…

The Sensitive Gut: A guide to managing common gastrointestinal disorders

When your digestive system is running smoothly, you tend not to think about it. Once trouble begins, your gut — like a squeaky wheel — suddenly demands your attention. This Special Health Report, The Sensitive Gut, covers the major sources of gastrointestinal distress: irritable bowel syndrome, gastric reflux, upset stomach, constipation, diarrhea, and excess gas. It also includes a special Bonus Section describing how emotional stress and anxiety can cause gastrointestinal distress.

Read More

Free Healthbeat Signup

Get the latest in health news delivered to your inbox!

Sign Up Close

Thanks for visiting. Don't miss your FREE gift.

25 Gut Health Hacks is yours absolutely FREE when you sign up to receive health information from Harvard Medical School.

Sign up to get tips for living a healthy lifestyle, with ways to lessen digestion problems…keep inflammation under control…learn simple exercises to improve your balance…understand your options for cataract treatment…all delivered to your email box FREE.

I want to get healthier This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Close

Health Alerts from Harvard Medical School

And a FREE copy of the new report 25 Gut Health Hacks!

Sign up to receive HealthBeat emails from Harvard Health Publishing and get helpful tips and guidance for ways to lessen digestion problems… keep inflammation under control… learn simple exercises to improve your balance… understand your options for cataract treatment… all delivered to your email inbox FREE. PLUS, you'll get the latest news on medical advances and breakthroughs from Harvard Medical School experts, and special offers on content from Harvard Health Publishing.

I want to get healthier This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Close

Stay on top of latest health news from Harvard Medical School.

Plus, get a FREE copy of 25 Gut Health Hacks.

Sign me up Close

Stay on top of latest health news from Harvard Medical School.

Plus, get a FREE copy of 25 Gut Health Hacks.

Sign me up This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.